WallStreetZenWallStreetZen

NASDAQ: AMRX
Amneal Pharmaceuticals Inc Stock Ownership - Who owns Amneal Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Amneal Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nikita ShahEVP2026-08-12146,403$17.51
$2.56MSell
Jason B. DalyCLO;EVP2026-08-12210,000$17.40
$3.65MSell
Jason B. DalyCLO;EVP2026-08-116,613$17.70
$117.05kSell
J. Kevin BuchiDirector2026-08-11168,573$17.18
$2.90MSell
Deborah M. AutorDirector2026-05-1134,819$12.94
$450.56kSell
Andrew S. BoyerExecutive Vice President2026-03-0419,136$13.30
$254.51kSell
Nikita ShahExecutive Vice President2026-03-0417,976$13.30
$239.08kSell
Chintu PatelCo-CEO2026-03-0428,983$13.30
$385.47kSell
Jason B. DalyEVP Chief Legal Officer2026-03-0415,580$13.30
$207.21kSell
Chirag K. PatelPresident Co-CEO2026-03-0437,825$13.30
$503.07kSell

1 of 5

AMRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AMRX insiders and whales buy or sell their stock.

AMRX Shareholders

What type of owners hold Amneal Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tushar Bhikhubhai Patel67.97%217,076,305$3.83BInsider
Chintu Patel17.94%57,276,759$1.01BInsider
Chirag K. Patel15.75%50,314,044$888.55MInsider
Gautam Patel15.12%48,273,095$852.50MInsider
Dipan 1. Patel8.42%26,905,073$475.14MInsider
Dipan Patel8.42%26,905,073$475.14MInsider
Blackrock Inc7.68%24,519,192$433.01MInstitution
Fosun International Ltd5.76%18,407,656$325.08MInsider
Ambient Impact Hk Ltd5.15%16,438,356$290.30MInsider
Tpg Group Holdings Sbs Advisors Inc5.08%16,213,367$286.33MInsider

1 of 3

AMRX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AMRX24.42%75.58%Net SellingNet Selling
INDV98.80%1.20%Net SellingNet Selling
LNTH51.87%48.13%Net Selling
SUPN45.70%54.30%Net Selling
ALKS93.36%6.64%Net SellingNet Selling
View Top Pharmaceutical Stocks

Amneal Pharmaceuticals Stock Ownership FAQ

Who owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals (NASDAQ: AMRX) is owned by 50.06% institutional shareholders, 154.99% Amneal Pharmaceuticals insiders, and 0.00% retail investors. Tushar Bhikhubhai Patel is the largest individual Amneal Pharmaceuticals shareholder, owning 217.08M shares representing 67.97% of the company. Tushar Bhikhubhai Patel's Amneal Pharmaceuticals shares are currently valued at $3.75B.

If you're new to stock investing, here's how to buy Amneal Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.